Effective cholesterol lowering after myocardial infarction in patients with nephrotic syndrome may require a multi-pharmacological approach: a case report

BACKGROUND: Nephrotic syndrome causes severe hypercholesterolaemia due to increased production and altered clearance of lipoproteins from the liver. It is challenging for patients with nephrotic syndrome and coronary heart disease to meet LDL-cholesterol (LDL-C) goals for secondary prevention with c...

Descripción completa

Detalles Bibliográficos
Autores principales: Sjuls, Simon, Jensen, Ulf, Littmann, Karin, Bruchfeld, Annette, Brinck, Jonas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Grand Round
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189300/
https://www.ncbi.nlm.nih.gov/pubmed/34124564
http://dx.doi.org/10.1093/ehjcr/ytab151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189300/
https://www.ncbi.nlm.nih.gov/pubmed/34124564
http://dx.doi.org/10.1093/ehjcr/ytab151

Ejemplares similares